DYRK1A and Alzheimer disease: A recent study suggests that neprilysin activity is suppressed directly or indirectly by dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A), so DYRK1A inhibition may also be a promising therapeutic target for AD through up-regulating neprilysin [15].